Mitochondrial-Targeted Molecular Imaging in Cardiac Disease

Area of Science:

• Cardiovascular Medicine
• Molecular Imaging
• Mitochondrial Biology

Background:

• Mitochondria are crucial for cellular energy production, apoptosis, and overall cardiac function.
• Mitochondrial dysfunction is implicated in various cardiac diseases.
• Current preclinical molecular imaging probes for mitochondria have limitations.

Purpose of the Study:

• To review the role of mitochondria in cardiac function and disease.
• To explore the potential of mitochondrial-targeted molecular imaging in assessing cardiac health.
• To highlight the development and application of novel imaging tracers.

Main Methods:

• Review of existing literature on mitochondrial function and cardiac disease.
• Discussion of mitochondrial-targeted molecular imaging probes and their development.
• Analysis of specific radiolabeled tracers (99mTc, 123I, 18F) for myocardial imaging.

Main Results:

• Mitochondrial-targeted molecular imaging can visualize cardiac dysfunction.
• Development of probes for myocardial metabolic activity, viability, perfusion, and blood flow shows promise.
• Novel tracers provide a direct link between mitochondrial dysfunction and cardiac pathology.

Conclusions:

• Molecular imaging offers a noninvasive, quantitative method to study in vivo mitochondrial function in the myocardium.
• Advanced molecular imaging tracers, particularly SPECT and PET, can provide detailed information on myocardial metabolism and restoration.
• Mitochondrial-targeted tracers are valuable tools for understanding and diagnosing cardiac diseases linked to mitochondrial dysfunction.